Plaintiffs say generic drug companies can't dodge US conspiracy claims
MLex Summary: Self-funded direct-action plaintiffs opposed a motion to dismiss US conspiracy claims against Teva Pharmaceuticals, Actavis, Heritage Pharmaceuticals, and other generic drug companies. “The amended complaint adequately alleges conspiratorial conduct...To view the full article, register now.
Already a subscriber? Click here to view full article